Adenosine deaminase activity and zinc levels in the serum of patients with diabetes mellitus

Rana Turkal 1 , Göksel Bahadır 2 , Yasemin Erdoğan Döventaş 2 , Goncagül Haklar 3 , Önder Şirikçi 3 ,  and Macit Koldaş 2
  • 1 Marmara University Pendik Training and Research Hospital, Department of Clinical Biochemistry Laboratory, Fevzi Çakmak Mah. Muhsin Yazıcıoğlu Cad. No: 10 Üst Kaynarca/Pendik İstanbul 34899, Turkey, Phone: +905354728118
  • 2 Haseki Training and Research Hospital, Department of Clinical Biochemistry Laboratory, İstanbul, Turkey
  • 3 Marmara University School of Medicine, Department of Biochemistry, İstanbul, Turkey
Rana Turkal, Göksel Bahadır, Yasemin Erdoğan Döventaş, Goncagül Haklar, Önder Şirikçi and Macit Koldaş

Abstract

Objective:

Adenosine deaminase (ADA) specifically catalyzes the deamination of adenosine which has been proved to play an important role in modulation of insulin action on glucose metabolism. Zinc is an essential micronutrient that is directly involved in the physiology of insulin and may be an important agent to activate the ADA. We aimed to evaluate serum ADA activity, zinc levels and the relationship between these two parameters in diabetes mellitus.

Methods:

We investigated serum ADA activity and zinc levels in type I (n = 100) and type II diabetes mellitus patients (n = 151).

Results:

ADA activities of diabetic patients were significantly elevated, whereas zinc levels were significantly lower than those of healthy controls (p < 0.001). Compared with the well-controlled diabetic patient groups (HbA1c < 7%), the poorly controlled diabetic groups (HbA1c > 8%) showed significantly increased ADA activity (p < 0.001). In contrast, zinc concentrations in the poorly controlled diabetic groups were not significantly different from those in the well-controlled diabetic patients (p = 0.246). Significant positive correlation was observed between ADA activity and HbA1c (r = 0.794). There was no correlation between ADA activity and zinc levels (r = 0.043; p > 0.05).

Conclusion:

Elevated ADA activity in diabetic patients with poor glycemic control may be a useful marker for therapy modulation.

  • 1.

    Rutkiewicz J, Gorski J. On the role of insulin in regulation of adenosine deaminase activity in rat tissues. Fed Eur Biochem Soc Lett 1990;27:79–80.

  • 2.

    Hoshino T, Yamada K, Masuoka K, Tsuboi I, Itoh K, Nonaka K, et al. Elevated adenosine deaminase activity in the serum of patients with DM. Diabetes Res Clin Pract 1994;25:97–102.

    • Crossref
    • PubMed
    • Export Citation
  • 3.

    Kurtul N, Pence S, Akarsu E, Kocoglu H, Aksoy Y, Aksoy H. Adenosine deaminase activity in the serum of type II diabetic patients. Acta Medica 2004;47:33–5.

  • 4.

    Chausmer AB. Zinc, insulin and diabetes. J Am Coll Nutr 1998;17:109–15.

    • Crossref
    • PubMed
    • Export Citation
  • 5.

    Al-Maroof R, Al-Sharbatti SS. Serum zinc levels in diabetic patients and effect of zinc supplementation on glycemic control of type II diabetics. Saudi Med J 2006;27:344–50.

  • 6.

    Yılmaz T. Tip I diabetes mellitus. In (Ed. Büyüköztürk K, Atamer T, Dilmener M, Erzengin F, Kayısı A, Ökten A) İç Hastalıkları 2007:2; pp. 489–500, Nobel Tıp Kitabevleri, İstanbul.

  • 7.

    Ellis G, Goldberg DM. A reduced nicotinamide adenine dinucleotide linked kinetic assay for adenosine deaminase activity. J Lab Clin Med 1970;76:507–17.

    • PubMed
    • Export Citation
  • 8.

    Green A. Adenosine receptor down-regulation and insulin resistance following prolonged incubation of adipocytes with an A1 adenosine receptor agonist. J Biol Chem 1987;262:15702–7.

    • PubMed
    • Export Citation
  • 9.

    Warrier AC, Rao NY, Kulpati DS, Mishra TK, Kabı BC. Evaluation of adenosine deaminase and peroxidation levels in diabetes mellitus. Ind J Clin Biochem 1995;10:9–13.

    • Crossref
    • Export Citation
  • 10.

    Barnett AH. Treating to goal: challenges of current management. Eur J Endocrinol 2004;151:3–7.

  • 11.

    Erciyas F, Taneli F, Arslan B, Uslu Y. Glycemic control, oxidative stress, and lipid profile in children with type 1 diabetes mellitus. Arch Med Res 2004;35:134–40.

    • Crossref
    • PubMed
    • Export Citation
  • 12.

    Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539–53.

    • Crossref
    • PubMed
    • Export Citation
  • 13.

    Budohoski L, Chllis RA, Cooney GJ, McManus B, Newsholme E. Reversal of dietary-induced insulin resistance in muscle of the rat by adenosine deaminase and an adenosine-receptor antagonist. Biochem J 1984;224:327–30.

    • Crossref
    • Export Citation
  • 14.

    Arquilla ER, Packer S, Tarmas W, Miyamoto S. The effect of zinc on insulin metabolism. Endocrinology 1978;103:1440–9.

    • Crossref
    • PubMed
    • Export Citation
  • 15.

    Faure P, Roussel AM, Martini M, Favier A, Halimi S. Insulin sensitivity in zinc depleted rats. Assessment with euglycemic hyperinsulinemic clamp technique. Diab Metab 1991;17:325–31.

  • 16.

    Quaterman J, Mills C, Humphries W. The reduced secretion and sensitivity to insulin in Zn deficient rats. Biochem Biophys Res Commun 1966;25:354–8.

    • Crossref
    • Export Citation
  • 17.

    Asano M, Okuda Y, Hirano K, Yamoaka T. Report of a case of pancreatic diabetes with severe zinc deficiency. J Jap Diab Soc 1995;38:317–522.

  • 18.

    Faure P, Corticelli P, Richard MJ, Arnaud J, Coudray C, Halimi S, et al. Lipid peroxidation and trace element status in diabetic ketone patients: influence of insulin therapy. Clin Chem 1993;5:789–93.

  • 19.

    Garg V, Gupta R, Goal R. Hypozincemia in diabetes mellitus. J Assoc Physicians India 1994;42:720–1.

    • PubMed
    • Export Citation
  • 20.

    Isbir T, Tamer A, Taylor A, Isbir M. Zinc, copper and magnesium status in insulin dependent diabetes. Diabetes Res 1994;26: 41–5.

    • PubMed
    • Export Citation
  • 21.

    Anderson RA, Roussel AM, Zouari N, Mahjoub S, Matheau JM, Kerkeni A. Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes. Am Coll Nutr 2001;20:212–8.

    • Crossref
    • Export Citation
  • 22.

    Nsonwu AC, Usoro CA, Etukudo MH, Usoro IN. Glycemic control and serum and urine levels of zinc and magnesium in diabetics in Calabar, Nigeria. Pak J Nutr 2006;5:75–8.

    • Crossref
    • Export Citation
  • 23.

    Viktorinova A, Toserova E, Krizko M, Durackova Z. Altered metabolism of copper, zinc, and magnesium is associated with increased levels of glycated hemoglobin in patients with diabetes mellitus. Metabolism 2009;58:1477–82.

    • Crossref
    • PubMed
    • Export Citation
  • 24.

    Zargar AH, Shah NA, Masoodi S, Laway BA, Dar FA, Khan AR, et al. Copper, zinc, and magnesium levels in non-insulin dependent diabetes mellitus. Postgrad Med J 1998;74: 665–8.

    • Crossref
    • PubMed
    • Export Citation
  • 25.

    Rusu ML, Marutoiu C, Rusu LD, Marutoiu OF, Hotoleanu C, Poanta L. Testing of magnesium, zinc and copper blood levels in diabetes mellitus patients. Seria F Chemia 2005;8:61–3.

  • 26.

    Canfield WK, Hambidge KM, Johnson LA. Zinc nutriture in type I DM: relationship to growth measures and metabolic control. J Ped Gastro Nutr 1984;3:577–84.

    • Crossref
    • Export Citation
  • 27.

    Diwan AG, Pradhan AB, Lingojwar D, Krishna KK, Singh P, Almelkar SI. Serum zinc, chromium and magnesium levels in type II diabetes. J Diab Dev Ctries 2006;26:122–3.

    • Crossref
    • Export Citation
  • 28.

    Kinlaw WB, Levine AS, Morley JE, Silvis SE, McClain CJ. Abnormal zinc metabolism in type II diabetes mellitus. Am J Med 1983;75:273–7.

    • Crossref
    • PubMed
    • Export Citation
  • 29.

    Fujimoto S. Studies on the relationship between blood trace metal concentration and the clinical status of patients with cerebrovascular disease, gastric cancer and diabetes mellitus. Hokoido Igaku Zasshi 1987;62:913–32.

  • 30.

    Brandao-Neto J, Silva CA, Figueiredo NB, Shuhama T, Silva JA, Oba L, et al. Renal handlig of zinc in insulin dependent diabetes mellitus patients. Biometals 2001;14:75–80.

    • Crossref
    • PubMed
    • Export Citation
  • 31.

    Franco R, Valenzuela A, Lluis C, Blanco J. Enzymatic and extraenzymatic role of ecto-adenosine deaminase in lymphocytes. Immunol Rev 1998;161:27–42.

    • Crossref
    • PubMed
    • Export Citation
  • 32.

    Coopers B, Sideraki V, Wilson DK, Dominguez DY, Clark SW, et al. The role of divalent cations in structure and function of murine adenosine deaminase. Protein Science 1997;6:1031–7.

    • Crossref
    • Export Citation
  • 33.

    Luo CH, Chen J, Yang XJ, Li YQ, Xu B, Zheng DY, et al. Influence of zinc deprivation on thymus, spleen development and adenosine deaminase activity in young rats. Hua Xi Yi Ke Da Xue Bao 1989;20:199–202.

  • 34.

    Gheim HK, Al-saleh S, Al-Shammary FJ, Kordee ZS. Changes in adenosine deaminase activity in ageing cultured human cells and the role of zinc. Cell Biochem Funct 2003;21:275–82.

    • Crossref
    • PubMed
    • Export Citation
Purchase article
Get instant unlimited access to the article.
€30.00
Log in
Already have access? Please log in.


or
Log in with your institution

Journal + Issues

Turkish Journal of Biochemistry (TJB), official journal of Turkish Biochemical Society, is issued electronically every 2 months. The main aim of the journal is to support the research and publishing culture by ensuring that every published manuscript has an added value and thus providing international acceptance of the “readability” of the manuscripts published in the journal.

Search